Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese medicine granule plus HAART for lipid metabolism abnormalities after HAART
ChiCTR-TRC-13003717Phase 4Completed
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Nov 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lipid-lowering Chinese medicine granules in dyslipidemia and human immunodeficiency virus infection (HIV) (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoints: CD4 cell count, HIV viral load and 5 more. Started Nov 2013; status: completed.
02
Drugs
lipid-lowering Chinese medicine granules
03
Conditions
dyslipidemiahuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR-TRC-13003717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003717.